**What is already known about the topic?**

-   Patients with life-limiting illness commonly experience considerable uncertainty, yet uncertainty is under-researched in the context of life-limiting illness.

-   Much of this uncertainty cannot be eliminated, yet clinicians are often reluctant to discuss uncertainty with their patients.

-   If poorly addressed, uncertainty can result in poorer psychological outcomes for patients and increase use of healthcare resources.

**What this paper adds?**

-   In-depth analysis of the experience of uncertainty for patients with a range of advanced illnesses.

-   Information needs, temporal focus and engagement with illness are key concerns for patients.

-   A typology of patient responses to uncertainty based on these three factors is developed to inform clinical practice.

**Implications for practice, theory or policy**

-   When managing patients with advanced illness and an uncertain prognosis, professionals should realise that uncertainty is often a central feature of patients' illness experience.

-   Our typology provides professionals with a framework to consider an individual patient's preferences in terms of temporal focus, information needs and engagement with illness.

-   This may help to tailor discussions with patients so that patients' priorities are addressed and information and support are provided according to their preferences.

Introduction {#section7-0269216316647610}
============

In our ageing population, an increasing number of people are living with advanced, life life-limiting illness.^[@bibr1-0269216316647610]^ Their care and treatment are further complicated by multi-morbidity and interactions between medical conditions. Patients can struggle with the complex healthcare system of which they become a part^[@bibr2-0269216316647610]^ and may experience a great deal of uncertainty regarding what treatments are best, the nature of their illness and the future.^[@bibr3-0269216316647610]^

The concept of uncertainty in illness has been widely studied^[@bibr3-0269216316647610][@bibr4-0269216316647610][@bibr5-0269216316647610][@bibr6-0269216316647610]--[@bibr7-0269216316647610]^ and can be understood to consist of uncertainty in relation to medical, personal and social domains.^[@bibr8-0269216316647610]^ Most definitions agree that, in essence, uncertainty comprises the inability to attribute meaning to events.^[@bibr3-0269216316647610],[@bibr9-0269216316647610]^ In her theory of uncertainty in illness, subsequently expanded to include chronic illness, Mishel^[@bibr4-0269216316647610],[@bibr5-0269216316647610]^ argues that disease complexity, poor information provision and the unpredictability or ambiguity of events interfere with patients' ability to confer meaning, thereby increasing uncertainty. Uncertainty is not necessarily a negative entity: it is patients' appraisal and response to uncertainty that mediates its impact.^[@bibr5-0269216316647610],[@bibr7-0269216316647610],[@bibr10-0269216316647610]^ For example, some patients will find prognostic uncertainty protective, as it allows them to 'look on the bright side', while others find not knowing what will happen distressing.

Research has mapped illness trajectories in several conditions,^[@bibr11-0269216316647610],[@bibr12-0269216316647610]^ and much work has been undertaken in the field of prognostication.^[@bibr13-0269216316647610],[@bibr14-0269216316647610]^ However, prognostication is based on professional judgement and inherently focuses on the clinician's perspective,^[@bibr2-0269216316647610],[@bibr15-0269216316647610]^ and there has been little attention to how patients themselves experience and cope with uncertainty in relation to prognosis. While experience of uncertainty has been investigated in some conditions,^[@bibr16-0269216316647610]^ there is limited evidence related to patient experiences of uncertainty in advanced illnesses, in which trajectories are difficult to determine. Since uncertainty as to future illness course cannot be eliminated, it is crucial to understand how patients with advanced illness cope with uncertainty and how uncertainty affects their support needs and preferences for communication with healthcare providers.

We know that if uncertainty is poorly addressed and managed, it can lead to negative emotional and psychological states for patients^[@bibr17-0269216316647610][@bibr18-0269216316647610]--[@bibr19-0269216316647610]^ and affect care delivery.^[@bibr20-0269216316647610]^ Unaddressed uncertainty may result in poor adaptation to illness,^[@bibr21-0269216316647610]^ adverse coping strategies, such as searching unrealistically for medical certainty, and conflict with health professionals.^[@bibr22-0269216316647610]^ Unresolved emotional issues related to poor communication have been associated with higher use of healthcare services^[@bibr23-0269216316647610]^ and poor communication of the uncertainties of cancer treatment with increased costs and higher risk of staff burnout.^[@bibr18-0269216316647610]^ Despite these effects, we know clinicians can be reluctant to raise uncertainty with patients,^[@bibr24-0269216316647610][@bibr25-0269216316647610][@bibr26-0269216316647610]--[@bibr27-0269216316647610]^ and this may be a reflection of current limits to medical education.

To address these negative outcomes and inform professionals' training needs, we need greater understanding of how patients experience and respond to uncertainty in advanced illness. This study aimed to understand experiences of uncertainty in patients with different advanced illnesses and develop a typology of their responses to uncertainty to inform future practice.

Methods {#section8-0269216316647610}
=======

We undertook secondary analysis of in-depth qualitative interview data from studies including patients with a range of advanced illnesses. Available to us were interviews from six studies of patients with: heart failure, chronic obstructive pulmonary disease (COPD), motor neurone disease (MND), renal disease, liver disease and metastatic cancer and patients in intensive care. All studies investigated illness experience from a patient perspective. We followed the consolidated criteria for reporting qualitative research (COREQ) guidelines for reporting qualitative analyses as far as these apply to secondary analysis.^[@bibr28-0269216316647610]^

Assessment for inclusion {#section9-0269216316647610}
------------------------

Data from different studies must be carefully assessed and found to be comparable if they are to be analysed together. We used criteria adapted from Stewart and Kamins^[@bibr29-0269216316647610]^ to assess whether it was reasonable to compare the studies based on study aim, data collection method, interview topic guide, data quality and timing of data collection ([Figure 1](#fig1-0269216316647610){ref-type="fig"}). Suitability for inclusion was discussed within the multidisciplinary research group. Following this process, two datasets were excluded: transcripts from the study in intensive care were not sufficiently relevant to the aims of this analysis (criterion 1) and data from patients with MND did not contain sufficient detail (criterion 2).

![Inclusion criteria -- assessment of comparability of qualitative data for secondary analysis.\
Source: Adapted from Stewart and Kamins.^[@bibr29-0269216316647610]^](10.1177_0269216316647610-fig1){#fig1-0269216316647610}

Sampling/selection {#section10-0269216316647610}
------------------

Five datasets^[@bibr30-0269216316647610][@bibr31-0269216316647610][@bibr32-0269216316647610][@bibr33-0269216316647610][@bibr34-0269216316647610]--[@bibr35-0269216316647610]^ containing 98 interview transcripts were eligible for inclusion ([Table 1](#table1-0269216316647610){ref-type="table"}). We screened all transcripts to identify those with content particularly relevant to the experience of uncertainty. This resulted in 73 transcripts with highly relevant or relevant content. We used purposive, maximum-variation sampling to select a sample of 30 interviews from these 73 transcripts. Sampling was based on patients' age, sex and diagnosis, with a preference for 'highly relevant' over 'relevant' content.

###### 

Details of included studies.

![](10.1177_0269216316647610-table1)

  Study                                                                        Population + sample                                                                                                  Sample size
  ---------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------- --------------------------------
  Renal study 1^[@bibr32-0269216316647610]^                                    Patients with advanced renal disease on conservative non dialytic pathway                                            16
  Renal study 2^[@bibr33-0269216316647610]^                                    Patients with end-stage renal disease on haemodialysis                                                               20
  Heart failure study^[@bibr30-0269216316647610],[@bibr31-0269216316647610]^   Patients with heart failure                                                                                          20
  AMBER care bundle evaluation^[@bibr35-0269216316647610]^                     Patients with uncertain recovery who are supported by the AMBER care bundle (cancer, renal disease, liver disease)   11
  Breathlessness study^[@bibr34-0269216316647610]^                             Patients with cancer, COPD, MND and heart failure experiencing breathlessness                                        48 (31 suitable for inclusion)

COPD: chronic obstructive pulmonary disease; MND: motor neurone disease.

Analysis {#section11-0269216316647610}
--------

Interview transcripts were analysed thematically using a combination of inductive and deductive coding.^[@bibr36-0269216316647610]^ Thematic analysis was selected as the most appropriate approach to identify patterns and broad themes from the data.^[@bibr37-0269216316647610]^ Following familiarisation with the data, one researcher (S.N.E.) developed the coding frame, with input from researchers who had conducted the analyses in the primary studies (K.B., L.E.S., F.E.M.M.) to finalise the coding frame. The researcher (S.N.E.) then applied the coding frame to the transcripts. During analysis, another researcher (K.Ba.) independently applied the coding frame to 10% of the transcripts. Discrepancies were resolved by discussion, with minor amendments to the coding frame. During analysis we recorded the new codes identified as each interview was analysed and considered that we had reached data saturation when no additional codes were identified. The final stage of analysis investigated the themes to identify a typology of patient responses to uncertainty.^[@bibr36-0269216316647610]^ This was verified by applying the typology to the raw data and checking for fit.

Ethics {#section12-0269216316647610}
------

The secondary analysis was in line with the aims of the primary research studies and the original ethical approvals obtained. Additional approval for the secondary analysis was obtained from King's College London Research and Development Service.

Results {#section13-0269216316647610}
=======

Demographic characteristics {#section14-0269216316647610}
---------------------------

Interviews with 30 patients were analysed. A total of 12 patients were women; median age was 75 years (range, 43--95 years). The interviews included patients with heart failure (*n* = 10), COPD (*n* = 4), renal disease (*n* = 10), cancer (*n* = 5) and liver disease (*n* = 1) ([Table 2](#table2-0269216316647610){ref-type="table"})

###### 

Demographic characteristics of sample.

![](10.1177_0269216316647610-table2)

                 Overall   Patients with heart failure                                 Patients with renal disease                                 Patients with COPD   Patients with cancer                                       Patients with liver disease
  -------------- --------- ----------------------------------------------------------- ----------------------------------------------------------- -------------------- ---------------------------------------------------------- -----------------------------
  *n*            30        10^[a](#table-fn3-0269216316647610){ref-type="table-fn"}^   10^[b](#table-fn4-0269216316647610){ref-type="table-fn"}^   4                    5^[c](#table-fn5-0269216316647610){ref-type="table-fn"}^   1
  \% female      40        20                                                          40                                                          75                   50                                                         0
  Age (median)   75        72                                                          83                                                          69                   62                                                         43
  Age (range)    43--95    57--80                                                      59--95                                                      54--75               52--84                                                     --

COPD: chronic obstructive pulmonary disease.

All from heart failure study.

Seven from renal study 1 and three from renal study 2.

All from AMBER care bundle evaluation.

Main themes {#section15-0269216316647610}
-----------

Four main themes emerged from the analysis, relating to: (a) patients' engagement with the illness process, (b) the period of time which patients mainly focused their attention on (denoted as 'temporal focus'), (c) patients' understanding of illness and information preferences and (d) patients' priorities in the context of an uncertain future (see [Figure 2](#fig2-0269216316647610){ref-type="fig"}). All four main themes were expressed by patients across the different disease groups.

![List of themes and sub-themes. Four main themes with list of sub-themes.](10.1177_0269216316647610-fig2){#fig2-0269216316647610}

### Patients' engagement with the illness process: control and loss of control {#section16-0269216316647610}

The theme of engagement relates to how involved patients wanted to be in illness decisions when prognosis was uncertain. In particular, some patients sought control over these decisions, and others ceded control to health professionals and/or family members. Some patients preferred to be strongly engaged with their care, either at a general or specific level: "Yes ... really involved ... they give me enough time to decide if I want ... yes or no ... they give me enough time ... don't know about anybody else but of myself ... I've got enough time ... they will even come back to ask me ... but um ... I can think about what they have said and so I'm happy with that. (A5CP3, 52-year-old male patient with cancer)"

Others preferred to cede control over their treatment to health professionals. Several patients felt that it was inappropriate for them to be involved with treatment decisions: "They give me the tablets, I take the tablets, I go away, I'm quite happy if they're working, I'm quite happy. It's when they're not working then I have to go and see a doctor -- then you have to accept what the doctor's going to do. (HF2a, 59-year-old male patient with heart failure)"

In addition to engaging with treatment decisions, some patients felt that maintaining independence in an uncertain future was a priority: "You know erm as long as, as long as I stay well and out of hospital and I can remain as independent as I can, keeping my indepen-, once my independence goes that will be me finished. I wouldn't, I wouldn't want people coming in here to wash me, dress me and that sort of thing ... Once I've lost my independence that would be me. I would want, I would want the end stage to come quickly. (KP015, 72-year-old female patient with COPD)"

Conversely, others were more concerned about areas where they had lost control over their lives due to illness. Some patients found it difficult to be limited by their illness:

Respondent:

When I walked out on the river front a couple of hours, stay out there, no problems at all! Now I, I have to, no, I ain't going, I got that fear of going through that door, just in case something might happen between going down there and coming back again.

Interviewer:

So that's a change for you ... you're quite anxious about -

Respondent:

I'm wary, very, very wary about goin'. (HF2a, 59-year-old male patient with heart failure)

### Temporal focus: facing an uncertain future {#section17-0269216316647610}

This theme describes the period of time that patients were most focused on and in particular patients' thoughts and feelings about their future. While some patients focused mainly on their current health status, others focused on future possibilities. This was partly determined by clinical events; for example, patients receiving ongoing complex treatment tended to focus more on the present. Conversely, a recent serious illness event was associated with patients thinking more about the future; this was particularly apparent in the interviews with patients with heart failure. Some patients were attentive to both the present and the future. This is well illustrated in the interviews with patients with renal disease, where those receiving haemodialysis tended to be more focused on the present, while those receiving conservative care focused more on possible future events:

Interviewer:

Do you feel the staff give you enough opportunity to talk about your care in the future?

Respondent:

As I said, I don't even think about that, I just take it day to day (HDMar, 59-year-old female patient with renal disease on haemodialysis)

"They said 'Well you, you've got a bit of a kidney problem'. I don't think it was very severe at that stage ... but, but it, it's gradually got worse since I've gone on, and now I'm told that I'm just on the borderline, if anything happens it won't be very pleasant as it were ... I accept that. (RG29, 84-year-old male patient with renal disease on conservative pathway)"

Patients who considered their future did so in different ways. Some patients contemplated possible future scenarios such as deterioration or what might happen at the end of their lives. Others were more practical and considered in detail what might happen to their families or finances in future.

### Information needs and preferences {#section18-0269216316647610}

#### Patients' understanding of illness {#section19-0269216316647610}

Most patients understood the 'big picture' of their likely prognosis. Several patients stated 'I'm going to die' when asked what the future held. However, patients expressed uncertainty about the illness journey ahead of them and the complexities of their treatment. Most patients described complexity in their illness course. Many had multiple illnesses and were looked after by more than one healthcare team. Complexity frequently resulted in patients having poor understanding of their illness:

Interviewer:

Yeah ... and do you feel they ... they understand your concerns?

Respondent:

Yeah ... oh yeah they're very understanding ... I say when you're in here they're very, very good, very understanding, very helpful ... it uh ... it's me that doesn't understand. (ACPt4, 84-year-old male patient with cancer)

Some patients responded to this complexity by seeking information and engaging with their illness, whereas others disengaged from their illness entirely. Another group experienced frustration at the complexities of illness, and this was sometimes expressed as concerns about continuity of care: "I always get confused when I go to hospital as to who is actually looking after me -- you have a series of consultants or whatever they are, house you know, which ... all very informative, they go round in a team and then one day one disappears one evening and I wonder who he was. (HF15a, 75-year-old male patient with heart failure)"

#### Information preferences {#section20-0269216316647610}

There was considerable variation in patients' information preferences. At one end of the spectrum were patients who wished to be informed fully: "I've always find that if I ask them something they've told me straight forward! I'm not frightened of bad news. You know, and I'm not frightened. (HF9a, 69-year-old male patient with heart failure)"

Others preferred to have no information about their illness, even if having more information might change their behaviour.

Interviewer:

Would you rather have not heard?

Respondent:

Yes (emphatic) ... But mind you, I heard, \[and\] it is going to prolong my life because I \[will\] be more careful ... but I would have preferred not to have heard.

Interviewer:

So there are advantages to hearing about it ...

Respondent:

There are advantages, yes, because I am more careful.

Interviewer:

But also disadvantages?

Respondent:

Disadvantages, that's it.

Interviewer:

So on balance ...?

Respondent:

On balance, not to tell me. \[Very definite here\] (RK21, 82-year-old male patient with renal disease)

### Patient priorities in the context of an uncertain future {#section21-0269216316647610}

Patients were appreciative when their priorities were addressed by healthcare professionals. Patient priorities related to four areas: appropriate communication, quality versus quantity of life, social factors and co-morbidities. Patients wanted to get the amount of information about their illness that was right for them, communicated in the right way and with the right people present. There were consequences if this procedure wasn't followed:

Respondent:

and then one of the other ones of the team came in and out the blue he said we're going to do a biopsy and if it's um ... malignant we can't do anything

Interviewer:

Mmm ...

Respondent:

So me son's gone mad, he says he's no right to say that to me without speaking to him first and he's had a word with them ... told them er what he thought and he said in future you contact me first ... they came in the following day and did the same thing and it's like nobody had anything positive, you know, it was all um gloom and doom. Well, of course you'll have more bad days than good days ... don't want to be told that. (A3Cp1, 67-year-old female patient with cancer)

Most patients prioritised quality of life when making decisions about their care. Some were happy to sacrifice quantity of life for quality: "So that ... I felt, in general, it wouldn't alter my ... I wouldn't get such a, a good quality of life as I'm now getting. Now I understand that not having dialysis may reduce my life by ... I don't know, maybe six months or may even be a year, but I would have had all this time ... good quality, I've got a very good quality, well you can see the cards, birthday. So I've got a very good quality of life. (RG29, 84-year-old male with renal disease on conservative pathway)"

Several patients prioritised others over themselves when considering the future. For example, patients who were breadwinners for their family (in this sample, generally male) prioritised ensuring that their family were provided for after their death: "No it's not really, it's erm one of these questions that come up before in your mind but they're not as medical er make sure the missus has enough money to survive on (laughs) erm or at least the children are erm (pause) come and see their mum more often than they do. (HF21a, 67-year-old male patient with heart failure)"

Another, smaller group of patients felt that avoidance of isolation was vital and considered social contact a priority: "I'm not one to give in, I am not one to give in. I'll fight it to the last but I just want that little bit of confidence ... especially when you're on your own, you've got no one to sort of tell people how you feel. (KP018, 75-year-old female with COPD)"

A number of patients, predominantly with heart failure or on dialysis, prioritised health issues unrelated to their primary diagnosis, or features of living with illness they thought professionals considered unimportant. These priorities were less likely to have been addressed than issues that were of more concern to professionals:

Respondent:

I can't go out shopping

Interviewer:

So your kidney trouble stops you being able to ... to do that.

Respondent:

Well it's, no, it's not the kidney trouble ... it's the arthritis. To be truthful I don't even know I've got kidney trouble. \[Patient receiving haemodialysis during interview\] (RDAu, 82-year-old female patient on haemodialysis)

Other patients reported that health professionals prioritised unimportant issues and were often distressed by the conflict in priorities and lack of communication about this: "... the only problem is, they keep poking me and I know there's no blood ... well there's blood left, but they don't seem to realise I've got nowhere for them to poke anymore ... so that's the only thing I would say ... leave me arms alone. (A10AP1, 56-year-old female with cancer)"

Typology of patient responses to uncertainty {#section22-0269216316647610}
--------------------------------------------

Based on the themes in our data, we developed a typology of patient responses to uncertainty in advanced illness. Three factors determined patients' response. First, patients had varying *levels of engagement* with their illness, treatment and the future, ranging from complete disengagement and delegation to medical professionals to close attention to all aspects of care. Second, in facing the future, patients' *temporal focus* was on the present, on possible future events, or, for some patients, on both. Finally, patients' *information preferences* ranged from wanting to know all the facts to not wanting any information.

Three main types were seen: (a) patients who were disengaged did not want information and focused on the present, (b) patients who were fully engaged wanted full information and considered the present and future and (c) patients who expressed intermediate views on one or all of these scales ([Figure 3](#fig3-0269216316647610){ref-type="fig"}).

![Typology of patient responses to uncertainty with three examples (3 a,b,c). 'Level of engagement' describes the extent to which patients are actively involved in thinking about and making decisions about their illness. 'Information preferences' describes patient information preferences, ranging from preferring no information about illness to preferring full and detailed information. 'Temporal focus' describes whether patients are focused on the future or on current events.](10.1177_0269216316647610-fig3){#fig3-0269216316647610}

Discussion {#section23-0269216316647610}
==========

In this study, the first to explore patient experiences of uncertainty in depth across a range of advanced illnesses, we found that patients' level of engagement with their illness, information preferences and temporal focus when facing the future are key factors in determining their response to uncertainty.

We found that patients' experiences of uncertainty and the priorities they expressed were remarkably similar across the disease groups. There were exceptions to this: in particular patients with heart failure or COPD more frequently described being affected by unpredictability (in line with the organ failure disease trajectory^[@bibr12-0269216316647610]^). Patients with heart failure more commonly described a previous serious event and its impact. Finally, patients with renal failure who were receiving dialysis and patients with heart failure described more experiences of conflict between their own priorities and those of their medical team. These differences warrant further investigation in primary qualitative research studies. As the experience of uncertainty is not unique to patients, further research into caregiver experiences of uncertainty is also needed to shed light on how uncertainty affects caregivers.

Our findings are largely supportive of Mishel's^[@bibr5-0269216316647610]^ established theory of uncertainty in illness, which specifies four underlying factors: complexity, unpredictability, lack of information and ambiguity. We have found complexity and unpredictability of illness to be a major part of the uncertainty experience for patients with advanced illness. Communication was a major theme, and this relates to the 'lack of information' aspect of Mishel's theory. The final aspect in Mishel's classification, 'ambiguity concerning the state of the illness', occurs when patients are unclear as to the meaning of illness-related events, due to unfamiliarity or complexity of events. This concept was considered less frequently by our patients and the reason for this is unclear. It may be that our secondary analysis design was insufficient to isolate ambiguity. Alternatively, it may be that once illness becomes advanced, there is less ambiguity about the illness course itself, though other uncertainties remain. Patients may also find it difficult to express their views on ambiguity or may attempt to attribute their own meanings to illness events to 'cover up' ambiguity.^[@bibr38-0269216316647610]^ There is some evidence that ambiguity in the context of advanced disease is an immobiliser -- that it prevents understanding and hence limits expression and decision making.^[@bibr39-0269216316647610],[@bibr40-0269216316647610]^ Further research investigating patient responses to ambiguity will help to clarify this.

Our typology of uncertainty also links well with existing theoretical positions. In their concept analysis of uncertainty, McCormick^[@bibr3-0269216316647610]^ identified temporality as one of the key aspects of uncertainty, which corresponds to the temporal focus aspect of our typology. Research in renal disease has also highlighted the importance of temporality to patients with advanced illness and an uncertain trajectory.^[@bibr33-0269216316647610]^ Mishel^[@bibr5-0269216316647610]^ noted that lack of information was one key contributor to the appraisal of uncertainty, which is reflected in our model's information needs factor. McCormick and Mishel identified other aspects of the construct of uncertainty in illness: complexity, unpredictability, ambiguity and the probability of events occurring. We found that patients engaged to different degrees with these aspects, resulting in level of engagement as the third factor in our typology.

Our findings are highly relevant to clinical practice. Our typology provides professionals with a framework to gauge an individual patient's preferences in three key areas. This may help to structure discussions with patients so that information and support are tailored to patients' priorities. By providing patients with appropriate levels of information, involving them in decision making according to their level of engagement, and discussing present and/or future care according to their temporal focus, clinicians may be able to better individualise the care of patients with uncertain prognosis. Considerable evidence exists regarding communication and management of information preferences in advanced illness, particularly in cancer care.^[@bibr41-0269216316647610][@bibr42-0269216316647610]--[@bibr43-0269216316647610]^ But there is less evidence regarding management of patient engagement. Shared decision-making approaches have proven effective,^[@bibr44-0269216316647610]^ and patient activation approaches which aim to improve engagement have shown promise in other settings.^[@bibr45-0269216316647610]^ Adaptation of these approaches to the context of uncertain prognosis may help to shape practice. However, it is unclear whether we should aim to increase engagement or manage the existing level of patient engagement. In future, the typology we propose here could be used to undertake a mixed-methods evaluation of the impact of considering these aspects of uncertainty on clinical assessment and patient care.

Evidence suggests that professionals vary in their acknowledgement and recognition of uncertainty^[@bibr20-0269216316647610],[@bibr26-0269216316647610],[@bibr46-0269216316647610]^ and are often reluctant to discuss prognostic uncertainty.^[@bibr25-0269216316647610],[@bibr26-0269216316647610]^ Some have argued that this reflects inadequate training of healthcare professionals to deal with uncertainty.^[@bibr47-0269216316647610]^ Our findings concur with those of other studies demonstrating that patients frequently do want uncertainty to be made explicit.^[@bibr24-0269216316647610],[@bibr25-0269216316647610]^ However, each patient's priorities will be different, requiring an individually tailored approach. There are multiple factors involved in patients' responses to uncertainty, which can be protective as well as harmful, and it is likely that professionals require more extensive training to enable them to effectively manage uncertainty. Future research should investigate professionals' training needs in this area.

This study has both strengths and weaknesses. The secondary analysis design of this study allowed us to investigate the experience of uncertainty in a wide range of advanced illnesses and in a group of mixed age and gender. This increases the transferability of our findings and allows us to comment to some extent on the effects of different aspects of illness on the experience of uncertainty. We were able to pursue a maximum-variation sampling strategy while selecting transcripts containing the richest data relevant to our research questions. The input of authors of the primary studies ensured that the data were used appropriately and resulted in a more robust coding frame. The secondary design is a limitation, in that using data from different studies inevitably means differences between the transcripts analysed, despite our care to ensure the included studies were comparable. The secondary analysis approach means that we lacked control over what questions were asked; differences in probing between interviews resulted in richer data in some studies compared to others. We were particularly aware during analysis that data from the heart failure study were very rich, while interviews with COPD patients included less probing and fewer follow-up questions.

Our sample included more male than female patients with heart failure, while the cancer patients formed a younger demographic. This, along with the absence of advanced neurological illness, means that our data are not representative of all patients with advanced illness, though the disease groups included were fairly well represented. Finally, the coding frame was applied by a single researcher with only 10% cross checking of coding; full dual coding would have increased rigour further.

Conclusion {#section24-0269216316647610}
==========

Uncertainty is a key component of the illness experience for patients with advanced illness. The evidence-based typology we present allows us to better understand patient responses in situations of uncertainty and develop strategies to address it in clinical practice. Better understanding and communication around uncertainty in the clinical setting can improve information provision, help to engage and empower patients and facilitate patient-centred care.
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